Peter B. Bitterman

15.3k citations

151 papers · 11.1k indexed · 4 hit papers · h-index 57

Impact in

Pulmonary and Respiratory Medicine top 0.2%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Neonatal Respiratory Health Research
- Medical Imaging and Pathology Studies
- Occupational and environmental lung diseases
- Respiratory Support and Mechanisms
- Chronic Obstructive Pulmonary Disease (COPD) Research
Immunology and Allergy top 1%

Papers in

Pulmonary and Respiratory Medicine 87
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 53
- Neonatal Respiratory Health Research 35
- Medical Imaging and Pathology Studies 20
- Occupational and environmental lung diseases 11
- Pulmonary Hypertension Research and Treatments 9
Genetics 10

Co-authors: Ronald G. Crystal Stephen I. Rennard Vitaly A. Polunovsky Craig A. Henke Mark S. Peterson S. Adelberg Allan J. Hance Brendan A. Keogh
Journals: Journal of Clinical Investigation (14 papers)CHEST Journal (11 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (8 papers)American Journal of Respiratory and Critical Care Medicine (6 papers)American Journal of Respiratory Cell and Molecular Biology (6 papers)
Partner nations: United States Canada Sweden

In The Last Decade

Peter B. Bitterman

149 papers receiving 10.7k citations

Hit Papers

align trajectories log scale

Extracellular matrix as a driver of progressive fibrosis 2018 · 434 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Journal of Clinical Investigation
2014 Journal of Clinical Investigation
1984 New England Journal of Medicine
1984 New England Journal of Medicine

Peers

Countries citing papers authored by Peter B. Bitterman

Since Specialization

Citations

This map shows the geographic impact of Peter B. Bitterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter B. Bitterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter B. Bitterman more than expected).

Fields of papers citing papers by Peter B. Bitterman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter B. Bitterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter B. Bitterman. The network helps show where Peter B. Bitterman may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter B. Bitterman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter B. Bitterman Line = papers co-authored together Peter B. Bitterman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Brg1/PRMT5 nuclear complex epigenetically regulates FOXO1 in IPF mesenchymal progenitor cells American Journal of Physiology-Lung Cellular and Molecular Physiology ·Punitha Ezhilarasu, Libang Yang, Xia Hong, Adam Gilbertsen, Peter B. Bitterman, Craig A. Henke	2024	4
2	Tumor suppressors RBL1 and PTEN are epigenetically silenced in IPF mesenchymal progenitor cells by a CD44/Brg1/PRMT5 regulatory complex American Journal of Physiology-Lung Cellular and Molecular Physiology ·Libang Yang, Xia Hong, Karen Smith, Adam Gilbertsen, Punitha Ezhilarasu, Juan E. Abrahante, Peter B. Bitterman, Craig A. Henke	2024	2
3	IL-8 concurrently promotes idiopathic pulmonary fibrosis mesenchymal progenitor cell senescence and PD-L1 expression enabling escape from immune cell surveillance American Journal of Physiology-Lung Cellular and Molecular Physiology ·Libang Yang, Xia Hong, Adam Gilbertsen, Karen Smith, Emilian Racila, Peter B. Bitterman, Craig A. Henke	2023	12
4	Hypoxia enhances IPF mesenchymal progenitor cell fibrogenicity via the lactate/GPR81/HIF1α pathway JCI Insight ·Libang Yang, Adam Gilbertsen, Xia Hong, Alexey O. Benyumov, Karen Smith, Jeremy Herrera, Emilian Racila, Peter B. Bitterman, Craig A. Henke	2023	37
5	Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis JCI Insight ·Jeremy Herrera, Colleen L. Forster, Thomas Pengo, Ángeles Montero, Joe Swift, Martin A. Schwartz, Craig A. Henke, Peter B. Bitterman	2019	61
6	Distinct Cancer-Promoting Stromal Gene Expression Depending on Lung Function American Journal of Respiratory and Critical Care Medicine ·L Caroline, Laìa Masvidal, Carl Murie, Margarita Bartish, Svetlana Avdulov, LeeAnn Higgins, Todd W. Markowski, Mark S. Peterson, Jonas Bergh, Ping Yang, Charlotte Rolny, Andrew H. Limper, Timothy J. Griffin, Peter B. Bitterman, Chris H. Wendt, Ola Larsson	2019	18
7	IV. Mechanisms of Fibrosis6 American Review of Respiratory Disease ·Stephen I. Rennard, Peter B. Bitterman, Ronald G. Crystal	2015	0
8	Pathologic Regulation of Collagen I by an Aberrant Protein Phosphatase 2A/Histone Deacetylase C4/MicroRNA-29 Signal Axis in Idiopathic Pulmonary Fibrosis Fibroblasts American Journal of Respiratory Cell and Molecular Biology ·James Farmer, Xia Hong, Vidya Bodempudi, Judy Kahm, Polla Hergert, Karen Smith, Mark S. Peterson, Matthew W. Parker, Jeremy Herrera, Peter B. Bitterman, Craig A. Henke	2015	47
9	eIF4E Threshold Levels Differ in Governing Normal and Neoplastic Expansion of Mammary Stem and Luminal Progenitor Cells Cancer Research ·Svetlana Avdulov, Jeremy Herrera, Karen Smith, Mark S. Peterson, Flávio André Alves Britto, Thomas C. Beadnell, Kathryn L. Schwertfeger, Alexey O. Benyumov, J. Carlos Manivel, Shunan Li, Anja‐Katrin Bielinsky, Douglas Yee, Peter B. Bitterman, Vitaly A. Polunovsky	2014	13
10	Reemergence of Hedgehog Mediates Epithelial–Mesenchymal Crosstalk in Pulmonary Fibrosis American Journal of Respiratory Cell and Molecular Biology ·Biao Hu, Jianhua Liu, Zhe Wu, Tianju Liu, Matthew Ullenbruch, Lin Ding, Craig A. Henke, Peter B. Bitterman, Sem H. Phan	2014	51
11	Attacking a Nexus of the Oncogenic Circuitry by Reversing Aberrant eIF4F-Mediated Translation Molecular Cancer Therapeutics ·Peter B. Bitterman, Vitaly A. Polunovsky	2012	22
12	A Novel Zebrafish Embryo Xenotransplantation Model to Study Primary Human Fibroblast Motility in Health and Disease Zebrafish ·Alexey O. Benyumov, Polla Hergert, Jeremy Herrera, Mark S. Peterson, Craig A. Henke, Peter B. Bitterman	2012	13
13	Pathological integrin signaling enhances proliferation of primary lung fibroblasts from patients with idiopathic pulmonary fibrosis The Journal of Experimental Medicine ·Xia Hong, Deanna Diebold, Richard Seonghun Nho, D. Perlman, Jill Kleidon, Judy Kahm, Svetlana Avdulov, Mark S. Peterson, Aike Keno Johannes Hansen, Peter B. Bitterman, Craig A. Henke	2008	189
14	Eukaryotic Translation Initiation Factor 4E–Induced Progression of Primary Human Mammary Epithelial Cells along the Cancer Pathway Is Associated with Targeted Translational Deregulation of Oncogenic Drivers and Inhibitors Cancer Research ·Ola Larsson, Shunan Li, Avinash Hansada, Svetlana Avdulov, Mark S. Peterson, Karen Smith, Peter B. Bitterman, Vitaly A. Polunovsky	2007	132
15	Akt-mediated Liver Growth Promotes Induction of Cyclin E through a Novel Translational Mechanism and a p21-mediated Cell Cycle Arrest Journal of Biological Chemistry ·Lisa K. Mullany, Christopher J. Nelsen, Eric A. Hanse, Melissa Goggin, В. Пилипенко, Mark S. Peterson, Peter B. Bitterman, Arvind Raghavan, Gretchen S. Crary, Jeffrey H. Albrecht	2007	44
16	Fibrin Turnover in Lung Inflammation and Neoplasia American Journal of Respiratory and Critical Care Medicine ·Steven Idell, Andrew P. Mazar, Peter B. Bitterman, Suresh Mohla, Andrea L. Harabin	2001	43
17	Lovastatin Induces Fibroblast Apoptosis In Vitro and In Vivo : A Possible Therapy for Fibroproliferative Disorders American Journal of Respiratory and Critical Care Medicine ·Annie Tan, H. Levrey, A. G. Kamenev, Vitaly A. Polunovsky, Jeffrey B. Rubins, Peter B. Bitterman	1999	86
18	Lovastatin Induces Apoptosis in Malignant Mesothelioma Cells American Journal of Respiratory and Critical Care Medicine ·Jeffrey B. Rubins, NOELANI GOODYEAR-KA‘ŌPUA, Robert A. Kratzke, Annie Tan, Vitaly A. Polunovsky, Peter B. Bitterman	1998	90
19	Pathogenesis of pseudoxanthomatous salpingiosis. PubMed ·Jeffrey D. Seidman, Hendra Setiawan Irda Sopiyani, Peter B. Bitterman, Seena C. Aisner	1993	13
20	Identification and partial characterization of angiogenesis bioactivity in the lower respiratory tract after acute lung injury. Journal of Clinical Investigation ·Joan Miquel Verd Pericás, Vance D. Fiegel, Marnie L. Peterson, Michael R. Wick, David R. Knighton, Andrea Rosengarten, Peter B. Bitterman	1991	42

About Peter B. Bitterman

Peter B. Bitterman is a scholar working on Pulmonary and Respiratory Medicine, Genetics, Molecular Biology, Oncology and Immunology, having authored 151 papers that have together received 11.1k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (53 papers), Neonatal Respiratory Health Research (35 papers), PI3K/AKT/mTOR signaling in cancer (24 papers), Medical Imaging and Pathology Studies (20 papers), Occupational and environmental lung diseases (11 papers), RNA and protein synthesis mechanisms (11 papers), Polyamine Metabolism and Applications (9 papers) and Pulmonary Hypertension Research and Treatments (9 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.1k citations), Immunology and Allergy (486 citations), Immunology (1.5k citations), Cancer Research (905 citations) and Molecular Biology (3.8k citations). Peter B. Bitterman has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Ronald G. Crystal, Stephen I. Rennard, Vitaly A. Polunovsky, Craig A. Henke, Mark S. Peterson, S. Adelberg, Allan J. Hance, Brendan A. Keogh, Jeremy Herrera and Gary W. Hunninghake. Their work appears in journals such as Journal of Clinical Investigation, CHEST Journal, American Journal of Physiology-Lung Cellular and Molecular Physiology, American Journal of Respiratory and Critical Care Medicine and American Journal of Respiratory Cell and Molecular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact